Michael D Step Net Worth

The estimated Net Worth of Michael D Step is at least $490 Thousand dollars as of 11 May 2017. Michael Step owns over 13,000 units of Ritter Pharmaceuticals stock worth over $490,000 and over the last 9 years Michael sold RTTR stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Michael Step RTTR stock SEC Form 4 insiders trading

Michael has made over 4 trades of the Ritter Pharmaceuticals stock since 2016, according to the Form 4 filled with the SEC. Most recently Michael bought 13,000 units of RTTR stock worth $8,060 on 11 May 2017.

The largest trade Michael's ever made was buying 27,000 units of Ritter Pharmaceuticals stock on 7 January 2016 worth over $39,960. On average, Michael trades about 7,700 units every 49 days since 2015. As of 11 May 2017 Michael still owns at least 50,000 units of Ritter Pharmaceuticals stock.

You can see the complete history of Michael Step stock trades at the bottom of the page.

What's Michael Step's mailing address?

Michael's mailing address filed with the SEC is 1880 Century Park E #1000, Los Angeles, CA 90067, USA.

Insiders trading at Ritter Pharmaceuticals

Over the last 9 years, insiders at Ritter Pharmaceuticals have traded over $124,250 worth of Ritter Pharmaceuticals stock and bought 1,819,751 units worth $8,518,572 . The most active insiders traders include Noah Doyle, Venture Partners, L.P. Javelin, and Matthew W Foehr. On average, Ritter Pharmaceuticals executives and independent directors trade stock every 86 days with the average trade being worth of $1,400,057. The most recent stock trade was executed by Noah Doyle on 12 March 2020, trading 500,000 units of RTTR stock currently worth $110,000.

What does Ritter Pharmaceuticals do?

Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.

Complete history of Michael Step stock trades at Ritter Pharmaceuticals

Ritter Pharmaceuticals executives and stock owners

Ritter Pharmaceuticals executives and other stock owners filed with the SEC include:

• Ira Ritter,
  Director
• Amy Broidrick,
  Independent Director
• Kurt Kruger,
  Independent Director
• Matthew Korenberg,
  Independent Director
• Richard David,
  Independent Director
• Shishir Sinha,
  Vice President - Operations
• Wajdi Abdul-Ahad,
  Chief Scientific Officer, Vice President - Research & Development
• Christopher Lotz,
  Chief Financial Officer, Vice President - Finance
• Michael Poirier,
  Chairman of the Board, President, Chief Executive Officer
• Paul V Maier,
  Director
• Michael D Step,
  CEO
• William M. Merino,
  Director
• Ellen F. Mochizuki,
  VP, Finance
• Partners Llc Stonehenge,
  10% owner
• Matthew W Foehr,
  Director
• Gerald T Proehl,
  Director
• Venture Partners, L.P. Javelin,
  10% owner
• Andrew J Ritter,
  CEO and President
• Noah Doyle,
  Director
• Jeffrey S Benjamin,
  VP of Finance
• John W Beck,
  Chief Financial Officer
• Venture Partners I Spv I, L...,
  10% owner